atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments Jan 27, 2022
Trade To Black Podcast 20: Is the Selling In MSOS And Psychedelics Getting Overdone? A Frank Discussion Jan 23, 2022
atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R-ketamine Program Jan 12, 2022
